Industry Wire 196

July 28, 2024 Jake Fishman 0 min read
  1. 6 questions on Medicare’s proposed DTx codes.
  2. FDA’s longtime chief regulator of medical devices leaves agency.
  3. Why Optum backed out of acquiring Steward physician group.
  4. Top 30 healthcare lobbyists in Q2.
  5. Ochsner launches $10M early stage innovation fund.
  6. Prime Healthcare acquires 9 Ascension hospitals in Illinois. 
  7. CrowdStrike outage expected to cost healthcare industry nearly $2B.
  8. U.S. workforce confidence reaches new low.
  9. Los Angeles Department of Health Services hacked via “push notification spamming.”
  10. Twenty CFO exits in 2024.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Structural Heart May 18, 2026

Cardiac Wire’s State of The Transcatheter Valve May 18, 2026

It might feel like a transcatheter alphabet soup out there with all of the valve interventions that have come out in the last few years, but Cardiac Wire is here to help make sense of it all.

Structural Heart May 14, 2026

The Young TAVR Trend is Stabilizing May 14, 2026

Despite a TAVR popularity surge in recent years, a Vizient registry analysis suggests the procedure’s prevalence has stabilized in patients under 65, but there’s still significant debate on whether the young patient TAVR rate is appropriate.

Cardiovascular Disease May 11, 2026

BP Lowering Still Decreases CVD Risk Even in CKD May 11, 2026

Data from a new Lancet study suggests that patients with chronic kidney disease (CKD) might get similar cardiovascular protection from blood pressure drugs as the general population, giving physicians some certainty about how to approach BP in these patients.